Statement pursuant to SEBI (Share Based Employee Benefits), Regulations, 2014 for the financial year ended March 31,
2022
Sl. Particulars Employee Stock Option Plan, 2006 Restricted Stock Unit Plan, 2019
No. (“ESOP, 2006”) (“RSU, 2019”)
1 Date of shareholders’ July 5, 2006 August 1, 2019
approval
2 Total number of options Total number of options shall not Total number of options shall not
approved under Employee exceed 5% of the total paid up equity exceed 1% of the total paid up equity
Stock Option Plan, 2006 shares of the Company from time to shares of the Company from time to
and Restricted Stock Unit time. Paid up equity shares of the time. Paid up equity shares of the
Plan, 2019 Company as at March 31, 2022 are Company as at March 31, 2022 are
27,34,23,102. Accordingly, the 27,34,23,102. Accordingly, the
maximum no. of options that can be maximum no. of options that can be
granted by the Company is 1,36,71,155 granted by the Company is 27,34,231
(5% of 27,34,23,102) as on March 31, (1% of 27,34,23,102) as on March 31,
2022. 2022.
3 Vesting Requirements Vesting of the options shall take place in the manner determined by the
Nomination and Remuneration Committee at the time of grant provided the
vesting period shall not be less than 1 (one) year from the date of grant.
Vesting of options shall be subject to the condition that the Grantee shall be in
continuous employment with the Company and such other conditions and
exceptions as provided under Company’s ESOP, 2006 and RSU, 2019.
4 Exercise price or pricing The Exercise Price of each grant is The Exercise Price of each grant shall
formula determined by the Nomination and be the face value of the Share on the
Remuneration Committee at the time of date of exercise of RSU.
grant, provided that the Exercise Price
shall not be less than the closing market
price of the shares of the Company on
NSE/BSE on the day preceding the date
of grant of Options.
5 Maximum term of options The maximum term of options granted within which they shall be exercised is
granted decided by the Nomination and Remuneration Committee which is generally ten
years from the date of grant of the options.
6 Source of shares (primary, Primary
secondary or combination)
7 Variation in terms of During the year, no amendment/ modification/ variation has been made in terms
options of options granted by the Company.
8 Method used to account Equity‐settled share‐based payments to Equity‐settled share‐based payments
for ESOS ‐ Intrinsic or fair employees are measured at the fair to employees are measured at the fair
value value of the equity instruments at the value of the equity instruments at the
grant date. The fair value determined at grant date. The fair value determined
the grant date of the equity‐settled at the grant date of the equity‐settled
share‐based payments is expensed on a share‐based payments is expensed on
straight‐line basis over the vesting a straight‐line basis over the vesting
period. The cost/(reversal, due to period. The cost of share‐based
forfeiture) of share‐based payments to payments to employees for the year
employees for the year ended March 31, ended March 31, 2022 is Rs. Nil, due
2022 is Rs. (29.34) crores. to forfeiture.
9 Where the company opts Not Applicable Not Applicable
for expensing of the options
using the intrinsic value of
the options, the difference
between the employee
compensation cost so
computed and the
employee compensation
cost that shall have been
recognized if it had used the
fair value of the options
shall be disclosed. The
impact of this difference on
profits and on EPS of the
company shall also be
disclosed.
10 Weighted‐average exercise Details of weighted average exercise Details of weighted average exercise
prices and weighted‐ prices and weighted average fair values prices and weighted average fair
average fair values of of the options exercised during the values of the options exercised during
options shall be disclosed financial year ended March 31, 2022, the financial year ended March 31,
separately for options whose exercise price equals to the 2022, whose exercise price equals to
whose exercise price market price of the stock on the date of the market price of the stock on the
either equals or exceeds or grant: date of grant :
is less than the market price
of the stock. Weighted average exercise price ‐ Rs. Weighted average exercise price ‐ Rs.
1,743.45 1
Weighted average fair value ‐ Rs.
866.36 Weighted average fair value ‐ Rs.
1,270.18
11 Details of Options granted
during the financial year
ended March 31, 2022
i) Director* None 50,000 options granted to 1 (one)
Director during the financial year
ii) Senior Managerial 2,97,000 options granted to 5 (five) None
Personnel* Senior Managerial Personnel during the
financial year
iii) Any other employee In addition to information stated at None, other than (i) above.
who received a grant in point (ii) above, there are no grants to
any one year of Options employees which are more than 5% of
amounting to 5% or the total options granted during the
more of the Options financial year.
granted during that
year.
iv) Identified employees None
who were granted
Options during any one
year, equal to or
exceeding 1% of the
issued capital
(excluding outstanding
warrants and
conversions) of the
Company at the time of
grant.
12 A description of the method The fair value of each Options granted on The fair value of each Option
and significant assumptions May 27, 2021 and November 3, 2021 is granted on April 1, 2021, is
used during the year to estimated using the Black‐Scholes Option estimated using the Black‐Scholes
estimate the fair value of Pricing Model after applying the following Option Pricing Model after
options including the key assumptions: applying the following key
following information: assumptions:
May 27, May 27, November 03, April 1, 2021
2021 2021 2021
(a) (i) the weighted‐average 2,633.50 2,633.50 2542.45 2,603.95
values of share price
(ii) exercise price 2,633.50 2,633.50 2543.00 1.00
(iii) expected volatility 37.75% 34.62% 36.29% 37.32%
(iv) expected option life 3 Years 4 Years 3 Years 4.5 years
(v) expected dividends 0.6656% 0.6656% 0.6405% 0.6656%
(vi) the risk‐free interest 4.73% 5.37% 5.07% 5.79%
rate
(b) the method used and the Not Applicable
assumptions made to
incorporate the effects of
expected early exercise
(c) how expected Volatility Expected Volatility was determined by taking the daily volatility of the share price
was determined, including on NSE, over a period prior to the date of grant, corresponding to the expected
an explanation of the life of the options for each vesting.
extent to which expected
volatility was based on
historical volatility
(d) whether and how any other Not Applicable
features of the option grant
were incorporated into the
measurement of fair value,
such as a market condition.
13 Diluted EPS on issue of Rs. 57.96
shares pursuant to all the
schemes covered under
the regulations shall be
disclosed in accordance
with 'Indian Accounting
Standard 33 ‐Earnings Per
Share' issued by ICAI or any
other relevant accounting
standards as prescribed
from time to time
14 Relevant disclosures in All relevant disclosures have been made in the financial statements.
terms of the' Guidance
note on accounting for
employee share‐based
payments' issued by ICAI or
any other relevant
accounting standards as
prescribed from time to
time
*Some of the employees who were granted stock options under ESOP, 2006 during the year were later elevated to the
position of Director/ Senior Managerial Personnel.
Details of Option Movement during the Financial Year 2021‐22
Sl. No. Particulars Employee Stock Options Restricted Stock Units
Plan, 2006 Plan, 2019
1. Number of options outstanding at the 18,97,658 50,000
beginning of the year
2. Number of options granted during the year 5,78,500 50,000
3. Number of options forfeited / lapsed 13,07,170 50,000
during the year
4. Number of options vested during the year 51,490 50,000
5. Number of options exercised during the 37,180 50,000
year
6. Number of shares arising as a result of 37,180 50,000
exercise of options
7. Money realized by exercise of options Rs. 6.48 Crore Rs. 50,000
(INR), if scheme is implemented directly by
the Company
8. Loan repaid by the Trust during the year Not Applicable Not Applicable
from exercise price received
9. Number of options outstanding at the end 11,31,808 NIL
of the year
10. Number of options exercisable at the end 1,90,808 NIL
of the year